Fluorometry

NEONATAL T-GAL Screening Fluo

The NEONATAL T-GAL Screening Fluo is an enzymatic test for the fluorescence detection of galactose and galactose-1-phosphate in the context of neonatal screening for galactosemia. This quantitative test is performed from a drop of blood dried on blotting paper type 903® and 226.

Parameter screened

  • Total Galactose (D-Galactose et Galactose-1-phosphate)

Test Principle

D-Galactose et Galactose-1-phosphate isolated from dried blood spots react with an enzyme-coenzyme reagent containing alkaline phosphatase (AP), galactose dehydrogenase and NAD+. Galactose-1-phosphate is converted to galactose by AP. The oxidation of galactose by galactose dehydrogenase is driven by the reduction of the coenzyme NAD+ to NADH. The NADH produced catalyzes the action of the diaphorase enzyme on resazurin which is reduced to resorufin. The reaction is measured by fluorescence at a wavelength of 590 nm after an excitation at 544 nm. The signal intensity is directly proportional to the concentration of total galactose present in the sample.

Product Benefits

Easy: The test does not need a transfer step

Requires little biological material: use of a single punch.

Convenient: Similar protocol to NEONATAL PKU Screening Fluo and NEONATAL MSUD Screening Fluo kits

Fast: 75-minute incubation time

Sensitive: High sensitivity of the test due to the use of the fluorescence technique

Certification: CE mark

Illness

This test is designed to screen newborns for galactosemia using a dried blood sample on blotting paper type 903® or 226.

General information

Product code

  • I-MB-288 for 288 determinations
  • I-MB-576 for 576 determinations

Related products

They are talking about us

Go to our publications

More information ?

Contact-us
logo Zentech